<DOC>
	<DOCNO>NCT00271687</DOCNO>
	<brief_summary>This study aim provide preliminary data feasibility outcomes 12 week exercise program quality life men hormone refractory prostate cancer receive docetaxel-based chemotherapy .</brief_summary>
	<brief_title>A Pilot Study Exercise Patients With Docetaxel-Based Chemotherapy Hormone Refractory Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>diagnosis prostate cancer receive docetaxelbased chemotherapy CCI age 18 year approval oncologist inform write consent life expectancy le 6 month Karnofsky performance score le 70 contraindication exercise ( e.g . uncontrolled cardiac , respiratory , hypertensive psychiatric disorder ) unable understand , read , write speak English unable unwilling attend supervise exercise session 3 time weekly unable unwilling complete outcome assessment</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>exercise</keyword>
	<keyword>exercise therapy</keyword>
	<keyword>activity daily live</keyword>
	<keyword>quality life</keyword>
</DOC>